Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Natural Progesterone for the Treatment of Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
- Status
- COMPLETED
- Phase
- NA
Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Role of Repeat Resection in Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- NA
ASP8374 + Cemiplimab in Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- NA
Niraparib Combined With Radiotherapy in rGBM
- Status
- UNKNOWN
- Phase
- PHASE2
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
- Status
- UNKNOWN
- Phase
- PHASE2